期刊文献+

血清中IgA/C3比值在IgA肾病诊断预测中的价值及其与IgA肾病临床及病理联系 被引量:31

Value of serum IgA/C3 ratio in the diagnosis of IgA nephropathy and its correlation with the clinicopathological features
下载PDF
导出
摘要 目的探讨血清IgA/C3水平在IgA肾病诊断预测中的价值,及其与IgA肾病临床、病理之间的关系。方法收集自2009年11月~2015年2月于南方医科大学第三附属医院肾活检诊断的66例IgA肾病,111例其他肾小球疾病,40例无肾脏病的健康体检者。使用CRM470调整后的标准化免疫比浊法检测患者血清中IgA、C3,并计算IgA/C3比值。参照牛津分级及Lee氏分级分别对IgA肾病患者进行病理学分级。在比较血清IgA、IgA/C3比值在预测IgA肾病的价值时,通过绘制ROC曲线,并计算曲线下面积。结果 IgA肾病患者血清IgA/C3比值较其他肾小球疾病组和健康对照组明显升高,其ROC曲线下面积为0.776。血清IgA/C3比值升高与IgA肾病病理损伤程度无明显相关性。结论在未开展肾活检的医院及不接受行肾活检的患者,血清IgA/C3比值在IgA肾病诊断中可起一定辅助作用。 Objective To investigate the value of serum IgA/C3 ratio in the diagnosis of IgA nephropathy and explore its relationship with the clinicopathological features of the patients. Methods Sixty- six patients with IgA nephropathy, 111 with other glomerular diseases, and 40 healthy control subjects without kidney disease were tested for serum IgA and C3 levels using CRM470 adjusted standardized immune turbidimetric method, and the IgA/C3 ratio was calculated. According to Oxford and Lee's classification criteria, we analyzed the pathological grades of the renal biopsy samples from patients with IgA nephropathy. The ROC curve was used to assess the value of serum IgA and IgA/C3 ratio in predicting IgA nephropathy.Results Patients with IgA nephropathy had an elevated serum IgA/C3 ratio than those with other glomerular diseases and the control subjects, with an area under the ROC curve of 0.776. An elevated serum IgA/C3 ratio was not found to significantly correlate with the pathological grade of renal biopsy samples in patients with IgA nephropathy. Conclusion In the absence of renal biopsy findings, serum IgA/C3 ratio can help in the diagnosis of IgA nephropathy.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2015年第12期1683-1688,共6页 Journal of Southern Medical University
基金 国家自然科学基金(81270840)~~
关键词 IGA肾病 血清IgA/C3比值 血清IGA IgA nephropathy serum IgA/C3 ratio serum IgA
  • 相关文献

参考文献23

  • 1Berger J, Hinglais N. Intercapillary deposits of IgA-IgG[J]. J Urol Nephrol (Paris), 1968, 74(9): 694-5.
  • 2D'amico G. The commonest glomerulonephritis in the world: IgA nephropathy[J]. Q J Med, 1987, 64(245): 709-27.
  • 3Julian BA, Waldo FB, Rifai A, et al. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?[J]. Am J Med, 1988, 84(1): 129-32.
  • 4Donadio JV, Grande JP. IgA nephropathy[J]. N Engl J Med, 2002, 347(10): 738-48.
  • 5Zhou FD, Zhao MH, Zou WZ, et al. The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre [J]. Nephrol Dial Transplant, 2009, 24(3): 870-6.
  • 6Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies[J]. Kidney Int, 2004, 66(3): 920-3.
  • 7D'amico G. Clinical features and natural history in adults with IgA nephropathy[J]. Am J Kidney Dis, 1988, 12(5): 353-7.
  • 8Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases[J]. Am J Kidney Dis, 1997, 29(4): 526-32.
  • 9Li PK, Ho KK, Szeto CC, et al. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives [J]. Nephrol Dial Transplant, 2002, 17(1): 64-9.
  • 10Stratta P, Canavese C, Marengo M, et al. Risk management of renal biopsy: 1387 cases over 30 years in a single centre[J]. Eur J Clin Invest, 2007, 37(12): 954-63.

二级参考文献19

  • 1秦雯,陈楠.慢性肾脏病的全球流行状况[J].国外医学(内科学分册),2006,33(2):81-84. 被引量:42
  • 2Berger J, Hinglais N. Intercapillary deposits of IgA-IgG[J]. J Urol Nephrol (Paris), 1968, 74(9): 694-9.
  • 3Cai GY, Chen XM. Immunoglobulin A nephropathy in China: progress and challenges[J]. Am J Nephrol, 2009, 30(3): 268-73.
  • 4Barratt J, Peter T. Urine proteomics: the present and future of measuring urinary protein components in disease [J]. CMAJ, 2007, 177(4): 361-8.
  • 5Varghese SA, Powell TB, Budisavljevic MN, et al. Urine biomarkers predict the cause of glomerular disease [J]. JASN, 2007, 18(3): 913-22.
  • 6Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific peptidome patterns [J]. J Clin Investn, 2006, 116(1): 271-84.
  • 7Rocchetti MT, Centra M, Papale M et al. Urine protein profile of IgA nephropathy patients may predict the response to ACE- inhibitor therapy[J]. Proteomics, 2008, 8(1): 206-16.
  • 8Perez-Maceda B, Lopea-Bote JP, Lamga C, et al. Antibodies to dietary antigens in rheumatoid arthritis-possible molecular mimicry mechanism[J]. Clinica Chimiea Acta, 1991, 203(2-3): 153-65.
  • 9Komatsu H, Fujimoto S, Hara S, et al. Relationship be- tween serum IgA/C3 ratio and progression of IgA ne- phropathy[J]. Intern Med, 2004,43 (1) : 1023-1028.
  • 10Nakayama K, Ohsawa I, Maeda-Ohtani A, et al. Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment find- ings and prognostic grading[J]. J Clin Lab Anal, 2008, 22(2) ;114-118.

共引文献8

同被引文献208

引证文献31

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部